Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ethel Cesarman

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Journal of Medical Virology|May 22, 2024
Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiationEzequiel Lacunza, Anuj Ahuja, Omar A Coso, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
LINE-1 transposable element is expressed in Kaposi's sarcoma and regulates gene expression in KSHV-infected cellsSupriya Bhattacharya, Nilabja Roy Chowdhury, Anuj Ahuja, et al.
American Journal of Clinical Pathology|February 28, 2002
Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infectionDavid M Menke, Amy Chadbum, Ethel Cesarman, et al.
Blood|May 10, 2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphomaAriela Noy, Jeannette Y Lee, Ethel Cesarman, et al.
Journal of Virology|March 30, 2005
Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTAHeesoon Chang, Yousang Gwack, Dior Kingston, et al.
Journal of Virology|February 20, 2009
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphomaDaniel L Di Bartolo, Elizabeth Hyjek, Shannon Keller, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
EBV Triggers a Distinct Antiviral Response in HMC3 CellsNoah E Berkowitz, Alexander Nosov, Mark Nosov, et al.
Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Blood|March 17, 2011
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphomaLisa Giulino, Susan Mathew, Gianna Ballon, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivoPirita Pekkonen, Annika Järviluoma, Nadezhda Zinovkina, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Journal of Medical Virology|May 22, 2024
Unveiling the role of KSHV-infected human mesenchymal stem cells in Kaposi's sarcoma initiationEzequiel Lacunza, Anuj Ahuja, Omar A Coso, et al.
Biorxiv : the Preprint Server for Biology|May 18, 2026
LINE-1 transposable element is expressed in Kaposi's sarcoma and regulates gene expression in KSHV-infected cellsSupriya Bhattacharya, Nilabja Roy Chowdhury, Anuj Ahuja, et al.
American Journal of Clinical Pathology|February 28, 2002
Analysis of the human herpesvirus 8 (HHV-8) genome and HHV-8 vIL-6 expression in archival cases of castleman disease at low risk for HIV infectionDavid M Menke, Amy Chadbum, Ethel Cesarman, et al.
Blood|May 10, 2015
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphomaAriela Noy, Jeannette Y Lee, Ethel Cesarman, et al.
Journal of Virology|March 30, 2005
Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTAHeesoon Chang, Yousang Gwack, Dior Kingston, et al.
Journal of Virology|February 20, 2009
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphomaDaniel L Di Bartolo, Elizabeth Hyjek, Shannon Keller, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
EBV Triggers a Distinct Antiviral Response in HMC3 CellsNoah E Berkowitz, Alexander Nosov, Mark Nosov, et al.
Blood|May 26, 2005
Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010Lawrence D Kaplan, Jeannette Y Lee, Richard F Ambinder, et al.
Blood|March 17, 2011
A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphomaLisa Giulino, Susan Mathew, Gianna Ballon, et al.
Cell Cycle (Georgetown, Tex.)|December 9, 2014
KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivoPirita Pekkonen, Annika Järviluoma, Nadezhda Zinovkina, et al.
Pageof 15